1. Home
  2. SONN vs GFAI Comparison

SONN vs GFAI Comparison

Compare SONN & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • GFAI
  • Stock Information
  • Founded
  • SONN N/A
  • GFAI 2018
  • Country
  • SONN United States
  • GFAI Singapore
  • Employees
  • SONN N/A
  • GFAI N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • SONN Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • SONN Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • SONN 21.4M
  • GFAI 23.5M
  • IPO Year
  • SONN N/A
  • GFAI N/A
  • Fundamental
  • Price
  • SONN $5.90
  • GFAI $1.15
  • Analyst Decision
  • SONN Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • SONN 1
  • GFAI 1
  • Target Price
  • SONN $20.00
  • GFAI $4.50
  • AVG Volume (30 Days)
  • SONN 825.4K
  • GFAI 518.5K
  • Earning Date
  • SONN 08-13-2025
  • GFAI 09-25-2025
  • Dividend Yield
  • SONN N/A
  • GFAI N/A
  • EPS Growth
  • SONN N/A
  • GFAI N/A
  • EPS
  • SONN N/A
  • GFAI N/A
  • Revenue
  • SONN $1,000,000.00
  • GFAI $36,347,373.00
  • Revenue This Year
  • SONN $5,376.22
  • GFAI $5.66
  • Revenue Next Year
  • SONN N/A
  • GFAI $4.69
  • P/E Ratio
  • SONN N/A
  • GFAI N/A
  • Revenue Growth
  • SONN 1689.52
  • GFAI 0.18
  • 52 Week Low
  • SONN $1.08
  • GFAI $0.76
  • 52 Week High
  • SONN $19.30
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • SONN 74.18
  • GFAI 51.82
  • Support Level
  • SONN $2.71
  • GFAI $1.04
  • Resistance Level
  • SONN $4.35
  • GFAI $1.11
  • Average True Range (ATR)
  • SONN 0.58
  • GFAI 0.08
  • MACD
  • SONN 0.22
  • GFAI 0.01
  • Stochastic Oscillator
  • SONN 80.96
  • GFAI 42.53

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

Share on Social Networks: